UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ductal carcinoma in situ: to treat or not to treat, that is the question

British journal of cancer, 2019-08, Vol.121 (4), p.285-292

2019

Volltextzugriff (PDF)

Hey Robot, Tell It to Me Straight: How Different Service Strategies Affect Human and Robot Service Outcomes

International journal of social robotics, 2023-06, Vol.15 (6), p.969-982

2023

Volltextzugriff (PDF)

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-05, Vol.327 (20), p.1963

2022

Volltextzugriff (PDF)

Still Not Solved: A Call for Renewed Focus on User-Centered Teleoperation Interfaces

Frontiers in robotics and AI, 2022-03, Vol.9, p.704225-704225

2022

Volltextzugriff (PDF)

Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2951-2958

2014

Volltextzugriff (PDF)

Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials

Annals of surgical oncology, 2017-10, Vol.24 (10), p.2855-2862

2017

Volltextzugriff (PDF)

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

JNCI : Journal of the National Cancer Institute, 2016-09, Vol.108 (9), p.djw050

2016

Volltextzugriff (PDF)

Single Drop Cytometry Onboard the International Space Station

Nature communications, 2024-03, Vol.15 (1), p.2634-2634, Article 2634

2024

Volltextzugriff (PDF)

It's not what you think: shaping beliefs about a robot to influence a teleoperator's expectations and behavior

Frontiers in robotics and AI, 2023-12, Vol.10, p.1271337-1271337

2023

Volltextzugriff (PDF)

Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study

Clinical cancer research, 2022-05, Vol.28 (9), p.1871-1880

2022

Volltextzugriff (PDF)

Check Your Stereotypes at the Door: An Analysis of Gender Typecasts in Social Human-Robot Interaction

Social Robotics, 2015-01, p.554-563

2015

Volltextzugriff (PDF)

Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer

The Journal of molecular diagnostics : JMD, 2022-07, Vol.24 (7), p.775-783

2022

Volltextzugriff (PDF)

Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial

The Lancet (British edition), 2009-02, Vol.373 (9663), p.567-574

2009

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2008-04, Vol.26 (10), p.1588-1595

2008

Volltextzugriff (PDF)

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer

Journal of clinical oncology, 2023-12, Vol.41 (35), p.5356-5362

2023

Volltextzugriff (PDF)

Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Nature reviews. Cancer, 2022-12, Vol.22 (12), p.663-678

2022

Volltextzugriff (PDF)

Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3273-3281

2020

Volltextzugriff (PDF)

POSNOC—POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

BMJ open, 2021-12, Vol.11 (12), p.e054365-e054365

2021

Volltextzugriff (PDF)

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)

The lancet oncology, 2010-03, Vol.11 (3), p.266-274

2010

Volltextzugriff (PDF)

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

The Lancet (British edition), 2011-01, Vol.377 (9762), p.321-331

2011

Volltextzugriff (PDF)

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

Journal of clinical oncology, 2011-04, Vol.29 (12), p.1531-1538

2011

Volltextzugriff (PDF)

Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas

The New England journal of medicine, 2005-09, Vol.353 (10), p.988-998

2005

Volltextzugriff (PDF)

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study

Breast cancer research : BCR, 2022-12, Vol.24 (1), p.90-90, Article 90

2022

Volltextzugriff (PDF)

Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

Radiotherapy and oncology, 2020-01, Vol.142, p.52-61

2020

Volltextzugriff (PDF)

1 – 25 von 585

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(502)
Mit Volltextzugriff
(506)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(38)
Cancer Research
(27)
Blood
(26)
The Astrophysical Journal
(12)
Clinical Lymphoma, Myeloma And Leukemia
(11)
Critical Care Medicine
(9)
Resuscitation
(9)
The Lancet
(9)
Plant Physiology
(8)
European Journal Of Surgical Oncology
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Ductal carcinoma in situ: to treat or not to treat, that is the question

Hey Robot, Tell It to Me Straight: How Different Service Strategies Affect Human and Robot Service Outcomes

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

Still Not Solved: A Call for Renewed Focus on User-Centered Teleoperation Interfaces

Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study

Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

Single Drop Cytometry Onboard the International Space Station

It's not what you think: shaping beliefs about a robot to influence a teleoperator's expectations and behavior

Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study

Check Your Stereotypes at the Door: An Analysis of Gender Typecasts in Social Human-Robot Interaction

Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer

Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer

Learning to distinguish progressive and non-progressive ductal carcinoma in situ

Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials

POSNOC—POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study

Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

Suchergebnisse filtern